X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Clinical and Investigative Medicine

期刊標題檢索 CLIN INVEST MED 最新評論: No translation available (2024-02-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Clinical and Investigative Medicine]您好,您是該頁面的第 20788 位訪客。

期刊簡介
期刊名稱Clinical and Investigative Medicine Clinical and Investigative Medicine
LetPub Score
5.0
50 ratings
Rate

Reputation
6.4

Influence
3.5

Speed
7.0

期刊簡稱CLIN INVEST MED
ISSN0147-958X
E-ISSN1488-2353
h-index43
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.500.2840.311
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: General Medicine
Q2280 / 636

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Clinical and Investigative Medicine (CIM), publishes original work in the field of Clinical Investigation. Original work includes clinical or laboratory investigations and clinical reports. Reviews include information for Continuing Medical Education (CME), narrative review articles, systematic reviews, and meta-analyses.
官方網站http://cimonline.ca/index.php/cim
在線稿件提交https://cimonline.ca/index.php/cim/information/authors
開放訪問No
出版商The Canadian Society for Clinical Investigation
主題領域医学
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年1978
每年文章數9每年文章數趨勢
黃金OA百分比0.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q4

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ4151/189
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0147-958X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Easy
參考鏈接
相關期刊 【Clinical and Investigative Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JOURNAL OF CLINICAL INVESTIGATIONH-index: 447

    CiteScore: 24.50
    EMBO Molecular MedicineH-index: 90

    CiteScore: 17.70
    JOURNAL OF BIOMEDICAL SCIENCEH-index: 71

    CiteScore: 18.50
    CLINICAL SCIENCEH-index: 126

    CiteScore: 11.40
    Journal of Translational MedicineH-index: 87

    CiteScore: 10.00
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINEH-index: 80

    CiteScore: 12.30
    JOURNAL OF MOLECULAR MEDICINE-JMMH-index: 127

    CiteScore: 9.30
    ARCHIVES OF MEDICAL RESEARCHH-index: 72

    CiteScore: 12.50
    Orphanet Journal of Rare DiseasesH-index: 87

    CiteScore: 6.30
    XENOTRANSPLANTATIONH-index: 56

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    Journal of Translational Medicine255759
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE172448
    JOURNAL OF CLINICAL INVESTIGATION168255
    JOURNAL OF BIOMEDICAL SCIENCE131248
    CLINICAL SCIENCE88160
    MEDICAL SCIENCE MONITOR84729
    Advances in Experimental Medicine and Biology81140
    EMBO Molecular Medicine79444
    EXPERIMENTAL BIOLOGY AND MEDICINE75995
    JOURNAL OF MOLECULAR MEDICINE-JMM75283
  •  

    Clinical and Investigative Medicine Clinical and Investigative Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Clinical and Investigative Medicine] 的評論撰寫評論
作者: 东风谷松伟


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-01 09:19:29 評論於
No translation available
(0) 讚! | 东风谷松伟

作者: 平原天逸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-25 18:00:51 評論於
Will this magazine send a confirmation letter?
(0) 讚! | 平原天逸

作者: 平原天逸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-20 08:51:14 評論於
Has anyone delivered this magazine?
(0) 讚! | 平原天逸

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:18:55 評論於
The Science Citation Index (SCI), abbreviated as SCI, was founded in 1957 by the Institute for Scientific Information (ISI) in Philadelphia, USA. It is a citation database published by the ISI in 1961. SCI, Engineering Index (EI), and Conference Proceedings Citation Index (ISTP) are the three most famous scientific literature retrieval systems in the world. They are internationally recognized as the main tools for scientific statistics and evaluation, with SCI being the most important
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:43:44 評論於
ORCID is a unique identifier for open scholars (Researcher and Contributor ID). The ORCID ID is the unique and persistent academic identity of contributors, which distinguishes authors from other researchers and records all relevant research activities of the author. It is necessary to log in to each author's account and then associate it in the account information section
(0) 讚! | 维尔娜菲茨杰拉德

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 10:46:44 評論於
How to add ORCID iD if it is not provided when the article is published?
(0) 讚! | Oswald Edie

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 19:53:33 評論於
What is SCI?
(0) 讚! | 上清雨真

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 09:17:00 評論於
Oh no! Falling so badly, it's embarrassing to be seen, what a trashy magazine
(0) 讚! | 凌霄高洁

作者: 蒂龙斯特拉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-06-17 09:56:15 評論於
Review speed: 6.0 | Submission success rate: 25.0  
Experience sharing: It feels like there is not much difference between whether the reviewer provides comments or not. The review process takes too long, almost half a year, and the submission is still rejected
(0) 讚! | 蒂龙斯特拉

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-23 17:33:08 評論於
What era is it now, and the submission method is actually to send it to the editor-in-chief's email
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-23 10:07:13 評論於
Submission Procedure.. Manuscripts, including Tables, Figures and a Covering Letter should be submitted via email directly to the Editor: Dr. Jonathan Angel, jangel@ohri.ca. I'm speechless.. still submitting like this
(0) 讚! | 凌霄高洁

作者: Werner Longfellow


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-01-31 10:50:08 評論於
It's getting slower and slower, sweat
(0) 讚! | Werner Longfellow

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-11-15 10:30:51 評論於
The number of submissions received each year continues to increase, resulting in a relatively high rejection rate. The average review time is approximately 2-3 months
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Clinical and Investigative Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*